Skip to main content
BeiGene, Ltd. (BGNE)
NASDAQ: BGNE · Real-Time Price · USD
193.32
-0.95 (-0.49%)
Nov 21, 2024, 12:08 PM EST - Market open

BeiGene Revenue

BeiGene had revenue of 7.35B CNY in the quarter ending September 30, 2024, with 39.54% growth. This brings the company's revenue in the last twelve months to 23.51B, up 50.22% year-over-year. In the year 2023, BeiGene had annual revenue of 2.46B with 73.65% growth.

Revenue (ttm)
23.51B CNY
Revenue Growth
+50.22%
P/S Ratio
6.05
Revenue / Employee
2,217,710 CNY
Employees
10,600
Market Cap
20.54B USD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.46B1.04B73.65%
Dec 31, 20221.42B239.64M20.37%
Dec 31, 20211.18B867.41M280.83%
Dec 31, 2020308.87M-119.34M-27.87%
Dec 31, 2019428.21M229.99M116.03%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical 16.77B
Labcorp Holdings 12.71B
Quest Diagnostics 9.54B
STERIS 5.33B
Illumina 4.39B
Hologic 3.99B
The Cooper Companies 3.80B
Waters 2.91B
Revenue Rankings

BGNE News

More News